Oaktree Acquisition III Life Sciences Sponsor Plans Conversion of 4,798,758 Class B Shares to Class A

Oaktree Acquisition III Life Sciences' sponsor plans to convert 4,798,758 Class B ordinary shares into Class A ordinary shares one-for-one. The conversion is planned before an extension takes effect; shareholders will consider the business combination deadline extension on October 16, 2026. Following conversion, sponsor holdings will total 5,382,739 Class A ordinary shares and 1,000 Class B ordinary shares. Converted shares will retain Founder Share restrictions, including no redemption rights; the sponsor's voting power will remain unchanged. Assuming 13,326,977 redemptions and conversion, outstanding shares will total 11,254,791 Class A ordinary shares and 1,000 Class B ordinary shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oaktree Acquisition III Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by